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1178Objectives:We and others have reported the early experience with off-label use of thoracic aortic endografts to
facilitate the resection of tumors infiltrating the aorta. We describe our extended experience and long-term
outcome using this innovative approach.
Methods: Patients with preoperative suspected thoracic aortic infiltration who underwent endografting followed
by en bloc tumor resection including the aortic wall were retrospectively reviewed and data were analyzed.
Results: Between 2008 and 2012, 5 patients (4 female) with a median age of 52 years (34-63 years) were
included. Tumors infiltrating the aorta were non–small cell lung carcinomas (n ¼ 3) and sarcomas (n ¼ 2).
Both patients with sarcoma had neoadjuvant radiation, whereas patients with non–small cell lung carcinomas
had neoadjuvant (n ¼ 2) or adjuvant chemoradiation (n ¼ 1). Aortic endografting was performed 1 to 17
days before resection of the tumor. The proximal end of the stent-graft was deployed in the aortic arch
(n ¼ 2) or the descending aorta (n ¼ 3). The tumor was resected en bloc in all patients and combined with chest
wall and 2 to 3 levels of spinal resection in 4 of the 5 patients. Two patients with full-thickness aortic wall resec-
tion had additional buttressing of the defect. Cardiopulmonary bypass was never required. One patient had an
empyema requiring debridements and thoracic window. After a median follow-up of 39 months (range, 9-62
months), all patients were alive and disease-free. None of them had overt endograft-related complications.
Conclusions: Thoracic aortic endografting allowed safe en bloc resection of tumors invading the aortic wall.
Therefore, the indication for thoracic aortic endografts could be extended to specific oncologic cases. (J Thorac
Cardiovasc Surg 2014;147:1178-82)Surgical resection of tumors invading the aorta is a chal-
lenging procedure. It usually implies cardiopulmonary
bypass with or without hypothermia and circulatory arrest.1
The use of a passive shunt to avoid extracorporeal circula-
tion also has been described.2 More recently, we and others
reported the use of thoracic aortic endografts to facilitate en
bloc resection of tumors invading the aortic wall.3-5 We
describe our updated surgical experience and long-term
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The Journal of Thoracic and Cardiovascular SurMATERIALS AND METHODS
This is a retrospective single-center study. Patients with preoperative
suspected tumoral infiltration of the thoracic aorta who underwent endog-
rafting followed by en bloc resection of the tumor and aortic wall were
included. Data were retrospectively retrieved from patients’ electronic
charts. The study was approved by the institutional research ethics board
at University Health Network. Patient informed consent was obtained.
Preoperative Staging
In case of non–small cell lung cancer, preoperative evaluation
comprised computed tomography (CT) of the chest and abdomen, CT or
magnetic resonance imaging (MRI) of the brain, bone scan, or integrated
positron emission tomography with CT. MRI of the spine was performed
when its infiltration was suspected. The mediastinum was systematically
assessed by cervical mediastinoscopy or endobronchial ultrasound-
guided fine-needle aspiration. Induction therapy consisted of concurrent
chemoradiation with 2 cycles of cisplatin-etoposide and 45 Gy to the pri-
mary tumor. Restaging was performed with CTof the chest/abdomen, brain
MRI or CT, and spine MRI if necessary. Tumors were classified according
to the 7th edition of the TNM classification of malignant tumors.6
In case of sarcoma, preoperative radiotherapy with 50 Gy in 25 fractions
was administered to the tumor. Pre- and post-radiotherapy imaging was
performed with CT or MRI of the chest.
Surgical Technique
Surgical procedures were performed in 2 or 3 stages. Insertion of the
thoracic aortic endograft was performed before en bloc tumor resection.
Endografting was indicated if the preoperative CT showed evidence of
aortic compression or encircling on more than 180. Tumor resectiongery c April 2014
Abbreviations and Acronyms
CT ¼ computed tomography
MRI ¼ magnetic resonance imaging
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aortic endograft insertion. If the tumor involvement implied 3 vertebral
levels or more, a 2-stage procedure was performed for the spine resection
as previously described.7
Before thoracic aortic endografting, CT angiography from the supra-
aortic vessels to the common femoral arteries was performed to assess
for vessel size and anatomy. In instances of planned coverage of aortic
arch arteries, sealing of artery take-off followed by appropriate arterial
bypass or endovascular in situ fenestration via ipsilateral brachial artery
was performed during the same stage. In cases of inadequately sized
external iliac vessels, retroperitoneal access was used. An activated clotting
time of 300 seconds or more was targeted for the whole procedure. Endog-
rafts (Talent and Valiant fromMedtronic Inc, Minneapolis, Minn) were up-
sized by 10% or less compared with the native aorta. A proximal and distal
landing zone of 4 cm of healthy aorta was targeted for sufficient endograft
stability. Postprocedure CTangiogramwas performed to rule out endoleak.
Tumor resection was performed en bloc and included resection of the
involved aortic wall, lung, chest wall, and spine when necessary. Typical
2-stage procedure consisted of a posterior midline incision, posterior tumor
release, andmultilevel spine instrumentation for the first stage. In the second
stage, en bloc tumor resection with completion of the spine instrumentation
was performed through a posterolateral thoracotomy with or without re-
opening of the posterior midline incision. The chest wall was reconstructed
with a polypropylene (Marlex; C. R. Bard Inc, Cranston, NJ) or polytetra-
fluoroethylene (Gore-Tex; WL Gore & Associates, Flagstaff, Ariz) mesh.RESULTS
Between 2008 and 2012, 5 patients underwent insertion
of a thoracic aortic endograft to facilitate en bloc resection
of a tumor infiltrating the aortic wall. Patient characteristics
are described in Table 1. After a median follow-up of 39
months (range, 9-62 months), all patients were alive and
disease-free.
All 5 patients underwent aortic wall resection without
aortic clamping and cardiopulmonary bypass. Table 2 sum-
marizes the different types of combined surgical procedures
performed. R0 resection was achieved in all patients. The
median hospital length of stay for the sum of the 2- or
3-stage procedure was 16 days (range, 7-29 days). None
of the 5 patients had endograft-related complications,
such as paraplegia, stroke, endoleak, and graft migration.
Only 1 patient had major postoperative complications.
The early outcome of patients 1 and 2 have been
described in detail by Roche-Nagle and associates.3 Patient
1 had a history of multiple local recurrences of a low-grade
chest chondosarcoma. She presented with a new recurrence
at the level of the 8th thoracic vertebra (T8) and indenting
the posterior aspect of the aorta. The first surgical procedure
consisted of a posterior midline incision with posterior spi-
nal instrumentation T3-T12 and bilateral laminectomy for
resection of spinous processes T7-9. Four days later, she
underwent a straightforward insertion of a thoracicThe Journal of Thoracic and Carendovascular graft above the artery of Adamkiewicz. The
third stage occurred 2 days later through a thoracotomy
and reopening of the posterior midline incision (Figure 1).
Complete resection of the tumor required resection of the
whole aortic wall over 5 3 3 mm exposing the endograft.
The aortic defect was covered with pleura. Six weeks after
discharge, she underwent a thoracic window for empyema
secondary to parenchymal bronchopleural fistula, and an
omental flap was brought to cover the area of the involved
spine and aorta. After multiple wound and instrumentation
revisions for debridement and nonunion, the patient re-
mains disease-free at more than 5 years and is receiving
intermittent antibiotic therapy for minor hemoptysis. Clear
evidence of graft infection has not been established.
Patient 2 had a lung adenocarcinoma of the left upper
lobe involving the dome of the aortic arch. After a crossover
bypass from the right to the left common carotid artery was
performed (end-to-side anastomosis, 7-mm Dacron graft),
an endograft was deployed proximally up to the take-off
of the innominate artery with rapid ventricular pacing.
The endovascular graft covered the left common carotid
and subclavian arteries. To minimize the risk of endoleak,
the origin of the left carotid was ligated and an endovascular
plug was placed in the left proximal subclavian artery. Five
days later, the patient underwent en bloc tumor resection via
a left hemi-clamshell incision, including the media of the
aorta on one quarter of the aortic circumference and a width
of 3 cm (Table 2). Adjuvant chemoradiotherapy with 4 cy-
cles of cisplatin-vinorelbine and 60 Gy was administered.
The patient is alive without recurrence 53 months after
the surgery.
Patient 3 had multiple metachronous lung metastasis
from a femur osteosarcoma. After repeated resections,
recurrence was apparent as a pleural mass located behind
the aorta at the level of the carina on the left side
(Figure 2). A straightforward endograft insertion allowed
a partial aortic wall resection of 3 cm2, en bloc with the tu-
mor on the following day. Tumor recurred in a different
location along the pleura 13 months later requiring another
chest wall resection, and the patient is currently disease-free
at 39 months.
Patient 4 underwent a 3-stage procedure for a left lower
lobe adenocarcinoma invading the neural foramen of
T6-7. The endovascular graft was deployed 2 cm below
the left subclavian artery. Six days later, she underwent pos-
terior tumor release and instrumentation/stabilization from
T2-10. Finally, the tumor could be resected en bloc with an
area of 5 cm2 of aortic adventitium 11 days later.
Patient 5 had a squamous cell carcinoma of the left lower
lobe abutting the descending aorta over 180 and infiltrated
T6 vertebral body. The stent-graft was deployed at the distal
edge of the origin of the left common carotid artery,
covering the subclavian artery origin. Therefore, in situ
fenestration of the subclavian artery with balloon dilationdiovascular Surgery c Volume 147, Number 4 1179
TABLE 1. Patient characteristics
Patient no. Sex Preoperative therapy Histology (y)pTNM Postoperative therapy DFS (mo) Recurrence
1 Female Radiation Sarcoma — — 62 —
2 Male — NSCLC T4N0M0 Chemoradiation 53 —
3 Female Radiation Sarcoma — — 13 Local
4 Female Chemoradiation NSCLC T4N0M0 — 30 —
5 Female Chemoradiation NSCLC T3N0M0 — 9 —
DFS, Disease-free survival; NSCLC, non–small cell lung cancer.
General Thoracic Surgery Collaud et al
G
T
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artery. An iliac conduit (10-mmDacron, end-to-side anasto-
mosis) was used to safely accommodate the aortic stent-
graft delivery system because the diameter of the femoral
artery was too small. En bloc tumor resection was per-
formed 2 weeks later. A full-thickness aortic wall resection
was required to completely remove the tumor exposing the
aortic endograft over 3 cm in width and 5 cm in length.
Because the aortic stent started to protrude through the
aortic wall defect leading to some bleeding from the distal
insertion of the stent, the aortic defect was buttressed with
bovine pericardium to refrain the stent expansion
throughout the large aortic defect and stop the bleeding
(Figure 3). An additional left latissimus dorsi muscle flap,
which had been preserved at the time of the thoracotomy,
was brought on the aorta and the bronchovascular stumps.
After a 9-month follow-up, the patient has not had any
complication related to the endograft and remains free of
disease.
DISCUSSION
The first successful cases of endovascular stent-graft in-
sertions were described in 1991 and 1994 for abdominal
and thoracic aortic aneurysms, respectively.8,9 Currently,
endovascular thoracic stent-grafts are commonly used for
aortic aneurysms, dissection, traumatic injury, and rupture.
We described the off-label use of these endografts in theTABLE 2. Surgical procedures
Patient no.
No. of
stages
Aortic endografting
Proximal
landing zone
Additional
procedure Lung
Chest
wall
1 3 Descending
aorta
— Wedge
lower lobe
Ribs 7-
2 2 Aortic arch Carotid-carotid
crossover
Upper
lobectomy
—
3 2 Descending
aorta
— Lower
lobectomy
Ribs 5-
4 3 Descending
aorta
— Lower
lobectomy
Ribs 5-
5 2 Aortic arch In situ fenestration
of subclavian a
Lower
lobectomy
Rib 5-8
1180 The Journal of Thoracic and Cardiovascular Suroncologic setting for 5 patients and provided long-term
outcome data. Advantages of aortic endografting over
open surgery are linked to its minor invasiveness and
absence of requirement of cardiopulmonary or aorto-
aortic bypass use at the time of surgery.10-12 The absence
of bypass-related anticoagulation during the tumor resec-
tion phase allowed safe major en bloc resection as in our se-
ries. This was particularly helpful in case of spine
involvement by the tumor, where spine resection invariably
leads to profuse blood loss.
Some technical characteristics and pitfalls need to be
emphasized. The optimal delay between thoracic aortic en-
dograft insertion and aortic wall resection is not known. In
an experimental study involving endovascular stent-
grafting of the descending aorta of mongrel dogs, histologic
examination of the aortic wall revealed inflammation and
remodeling leading to progressive graft embedment.13
Indeed, full-thickness aortic wall resection was described
as ‘‘easy’’ immediately after stent-grafting and ‘‘difficult’’
7 days later because of aortic wall inflammation and dense
adhesions between the aorta and the stent-graft. In our se-
ries, the median delay was 5 days (range, 1-17 days). We
had never performed aortic endografting and resection dur-
ing the same anesthesia. This lapse of time allowed us to
assess the patient both clinically and radiologically for po-
tential complications of stent-grafting, such as paraplegia or
endoleaks, before proceeding with resection of the tumor.En bloc resection
Spine Aorta
Vertebrectomy Instrumentation Resection Reinforcement
9 Hemi T7-9 Posterior Adventitia-
media-intima
Parietal pleura
— — Adventitia-media —
7 Partial T5-6 — Adventitia-media —
7 Hemi T5-7 Posterior Adventitia —
Partial T5-8 — Adventitia-
media-intima
Bovine
pericardium,
latissimus
dorsi muscle
gery c April 2014
FIGURE 1. Anteroposterior spine x-ray after posterior spinal instrumen-
tation of T3-12 vertebras (first stage), endovascular stent-grafting of the
descending thoracic aorta (second stage), and en bloc tumor resection (third
stage). Note the hemivertebrectomy T7-9 and resection of their corre-
sponding ribs.
FIGURE 2. Preoperative axial CT view showing a lung metastasis from
an osteosarcoma invading the aortic wall.
FIGURE 3. Intraoperative view showing buttressing of the aortic full-
thickness defect with bovine pericardium, anchored with interrupted 4.0
Prolene.
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tion are lacking. In the previously cited experimental study,
full- or partial-thickness of the aortic wall (adventitia and
outer half of the media) was resected on 1 cm in width
and on one half or one quarter of the circumference.13 There
was no complication reported at 1 year except for resection
of one half of the aortic circumference. In fact, stenosis of
the aorta with proximal dilatation was detected at 6 months
and stable in size at 12 months on angiography. Because this
extensive aortic wall resection was not covered with a free
fascia patch compared with others, the authors could notThe Journal of Thoracic and Carconclude whether the extent of the resection or the absence
of covering was responsible for the aortic narrowing.
In our current series and 2 other reported cases, no
complication was encountered when partial-thickness of
the aortic wall and less than one half of the circumference
were resected.4,5 We encountered bulging of the endograft
out of the aortic wall defect in 1 patient after full-
thickness wall resection over 5 cm. However, this complica-
tion could be well managed with buttressing of the defect
with a patch of bovine pericardium. Large landing zones
for the endograft on healthy aorta are probably an important
component in stent-graft stability. We and others aimed to
stent the suspected area of aortic infiltration with a safe
proximal and distal margin of 4 cm of uninvolved aorta.
At the end of follow-up, none of our 2 patients had endoleak
or pseudoaneurysm formation.diovascular Surgery c Volume 147, Number 4 1181
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patches of abdominal rectus muscle fascia, parietal pleura,
bovine pericardium, omentum, or latissimus dorsi mus-
cle.4,5,13 In the study by Sasahara and colleagues,13 histo-
logic examination of the abdominal rectus muscle fascia
patch used to cover aortic defect showed a thicker collage-
nous tissue than in any other aortic wall region. Therefore,
aortic defect buttressing may strengthen the aortic wall,
increasing stent-graft stability and potentially avoiding
dangerous aortic fistula with neighboring structures.
CONCLUSIONS
In our experience, thoracic aortic endografting allowed
safe en bloc resection of tumors invading the aortic wall.
This option was particularly helpful for tumors extending
into the aortic wall and the spine. Therefore, we suggest
the extension of indication for thoracic aortic endograft to
specific oncologic cases. Routine preoperative aortic imag-
ing, including transesphageal echocardiography and intra-
vascular ultrasound, may help better define the indication
for endografting and should be assessed in the future.
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Dr Mathew Williams (New York, NY). In terms of staging, did
you do these all at the same time or did you place the endograft pre-
viously and then bring them back? In the patients in whom you re-
constructed the aorta, how did you control the aorta? Did you
clamp it or use an endo-occlusion balloon?
Dr Collaud.All these patients were staged before the aortic en-
dografting. All of our patients with non–small cell lung cancer had
T4 N0 lung cancer.We never clamp the aorta in any of our patients.
Dr Williams. How soon before the resection did you do the
endograft?
Dr Collaud. The endografting has been done from the first day
up to the 17th day. The longest delay was 17 days.
Dr Williams. But always at least 1 day?
Dr Collaud. Yes. We have never done both the endografting
and the resection during the same anesthesia to assess the patient
both clinically and radiologically for potential endograft-related
complications.
Dr Osman Al-Radi (Jeddah, Saudi Arabia). Is there a limit to
how much invasion of the aorta there has to be for this to be
feasible, like if the invasion is more than half of the circumference
of the aorta? Have you decided when not to do this in terms of
circumference and length?
Dr Collaud. The widest excision we performed was in patient
5, who had infiltration of half of the circumference of the aorta and
about the width of 4 cm. From this, I think half of the circumfer-
ence is the biggest aortic wall defect we can do if we remove the
full thickness.
There is an experimental study performed in mongrel dogs in
which they removed half of the circumference, and they also
started to have complications at the site of resection of the
wall. So it is probably safer to resect less than half of the
circumference.gery c April 2014
